Skip to content
Okami-lobo-occluder
  • Technology
    • LOBO Technology
    • SENDERO
  • Clinical Evidence
    • Case Reviews
    • Published Studies
    • Education
  • Reimbursement & Economics
  • News
  • Events
  • About
    • Team
    • Careers
  • Contact
Okami-lobo-occluder
  • Technology
    • LOBO Technology
    • SENDERO
  • Clinical Evidence
    • Case Reviews
    • Published Studies
    • Education
  • Reimbursement & Economics
  • News
  • Events
  • About
    • Team
    • Careers
  • Contact

Okami Medical Announces Closing Of $7.2M Series D Financing

June 24, 2020

Okami Medical Announces Closing Of $7.2M Series D Financing Read More »

Okami Medical Announces First Patients Treated With The LOBO Vascular Occluder

March 5, 2020

Okami Medical Announces First Patients Treated With The LOBO Vascular Occluder Read More »

Okami Medical Announces Major Milestones: FDA 510(k) Clearance and Key Patent for the LOBO Vascular Occluder

November 4, 2019

Okami Medical Announces Major Milestones: FDA 510(k) Clearance and Key Patent for the LOBO Vascular Occluder Read More »

Inceptus Announces Completion of Series B Financing for Okami Medical

July 25, 2017

Inceptus Announces Completion of Series B Financing for Okami Medical Read More »

← Previous 1 2
Okami-lobo-occluder

8 Argonaut, Suite 100
Aliso Viejo, CA 92656
info@okamimedical.com
949-446-9710

LOBO is a registered trademark and SENDERO is a trademark of Okami Medical in the United States and other countries. Copyright © 2025 Okami Medical. All rights reserved.

Linkedin-in X-twitter

Compliance

Data Privacy and Cookie Policy

Terms and Conditions